Blood serotonin levels in autism spectrum disorder: A systematic review and meta-analysis

European Neuropsychopharmacology

Volumn 24, Issue 6, 2014, Pages 919-929

  Gabriele, Stefano ^a,b   Sacco, Roberto ^a,b   Persico, Antonio M ^a,b,c  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c Mafalda Luce Center for Pervasive Developmental Disorders   (Italy)

Author keywords

5 HT; Autism; Biomarker; Endophenotype; Meta analysis

Indexed keywords

SEROTONIN; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTISM; CHILD; FLUOROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; PRIORITY JOURNAL; SEROTONIN BLOOD LEVEL; SYSTEMATIC REVIEW; THROMBOCYTE POOR PLASMA; THROMBOCYTE RICH PLASMA; BLOOD; BLOOD ANALYSIS; CHEMISTRY; ENDOPHENOTYPE; PROCEDURES;

BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; CHILD DEVELOPMENT DISORDERS, PERVASIVE; ENDOPHENOTYPES; HUMANS; PLATELET-RICH PLASMA; SEROTONIN;

EID: 84899906322     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2014.02.004     Document Type: Article

References (72)

1. Abramson R.K., Wright H.H., Carpenter R., Brennan W., Lumpuy O., Cole E., Young S.R. Elevated blood serotonin in autistic probands and their first-degree relatives. J. Autism Dev. Disord. 1989, 19:397-407.
2. American Psychiatric Association, 2013. Diagnostic and Statistical Manual of Mental Disorders (5th ed.) American Psychiatric Publishing, Arlington, VA.
3. Anderson G.M., Freedman D.X., Cohen D.J., Volkmar F.R., Hoder E.L., McPhedran P., Minderaa R.B., Hansen C.R., Young J.G. Whole blood serotonin in autistic and normal subjects. J. Child. Psychol. Psychiatry 1987, 28:885-900.
4. Anderson G.M., Hertzig M.E., McBride P.A. Brief report: platelet-poor plasma serotonin in autism. J. Autism Dev. Disord. 2012, 42:1510-1514.
5. Badcock N.R., Spence J.G., Stern L.M. Blood serotonin levels in adults, autistic and non-autistic children with a comparison of different methodologies. Ann. Clin. Biochem. 1987, 24:625-634.
6. Bogdanski D.F., Pletscher A., Brodie B.B., Undenfriend S. Identification and assay of serotonin in brain. J. Pharmacol. Exp. Ther. 1956, 117:82-88.
7. Bonnin A., Goeden N., Chen K., Wilson M.L., King J., Shih J.C., Blakely R.D., Deneris E.S., Levitt P. A transient placental source of serotonin for the fetal forebrain. Nature 2011, 472:347-350.
8. Brand T., Anderson G.M. The measurement of platelet-poor plasma serotonin: a systematic review of prior reports and recommendations for improved analysis. Clin. Chem. 2011, 57:1376-1386.
9. Cantor R.M., Kono N., Duvall J.A., Alvarez-Retuerto A., Stone J.L., Alarcón M., Nelson S.F., Geschwind D.H. Replication of autism linkage: fine-mapping peak at 17q21. Am. J. Hum. Genet. 2005, 76:1050-1056.
10. Chugani D.C., Muzik O., Behen M., Rothermel R., Janisse J.J., Lee J., Chugani H.T. Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann. Neurol. 1999, 45:287-295.
11. Chugani D.C. Neuroimaging and neurochemistry of autism. Pediatr. Clin. North Am. 2012, 59:63-73.
12. Connors S.L., Matteson K.J., Sega G.A., Lozzio C.B., Carroll R.C., Zimmerman A.W. Plasma serotonin in autism. Pediatr. Neurol. 2006, 35:182-186.
13. Cook E.H., Leventhal B.L., Freedman D.X. Free serotonin in plasma: autistic children and their first-degree relatives. Biol. Psychiatry 1988, 24:488-491.
14. Cook E.H., Leventhal B.L., Heller W., Metz J., Wainwright M., Freedman D.X. Autistic children and their first-degree relatives: relationships between serotonin and norepinephrine levels and intelligence. J. Neuropsychiatry Clin. Neurosci. 1990, 2:268-274.
15. Cook E.H., Fletcher K.E., Wainwright M., Marks N., Yan S.Y., Leventhal B.L. Primary structure of the human platelet serotonin 5-HT2A receptor: identify with frontal cortex serotonin 5-HT2A receptor. J. Neurochem. 1994, 63:465-469.
16. Cook E.H., Leventhal B.L. The serotonin system in autism. Curr. Opin. Pediatr. 1996, 8:348-354.
17. Coutinho A.M., Oliveira G., Morgadinho T., Fesel C., Macedo T.R., Bento C., Marques C., Ataide A., Miguel T., Borges L., Vicente A.M. Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism. Mol. Psychiatry 2004, 9:264-271.
18. Croonenberghs J., Delmeire L., Verkerk R., Lin A.H., Meskal A., Neels H., Van der Planken M., Scharpe S., Deboutte D., Pison G., Maes M. Peripheral markers of serotonergic and noradrenergic function in post-pubertal, caucasian males with autistic disorder. Neuropsychopharmacology 2000, 22:275-283.
19. Cuccaro M.L., Wright H.H., Abramson R.K., Marsteller F.A., Valentine J. Whole-blood serotonin and cognitive functioning in autistic individuals and their first-degree relatives. J. Neuropsychiatry Clin. Neurosci. 1993, 5:94-101.
20. de Villard R., Flachaire E., Thoulon J.M., Dalery J., Maillet J., Chauvin C., Quincy C., Renaud B. Platelet serotonin concentrations in autistic children and members of their families. Encephale 1986, 12:139-142.
21. Di Pino G., Moessner R., Lesch K.P., Lauder J.M., Persico A.M. Roles for serotonin in neurodevelopment: more than just neural transmission. Curr. Neuropharmacol. 2004, 2:403-418.
22. DiCicco-Bloom E., Lord C., Zwaigenbaum L., Courchesne E., Dager S.R., Schmitz C., Schultz R.T., Crawley J., Young L.J. The developmental neurobiology of autism spectrum disorder. J. Neurosci. 2006, 26:6897-6906.
23. Egger M., Smith G.D., Phillips A.N. Meta-analysis: principles and procedures. Brit. Med. J. 1997, 315:1533-1537.
24. Freitas B.C., Trujillo C.A., Carromeu C., Yusupova M., Herai R.H., Muotri A.R., Stem cells and modeling of autism spectrum disorders, Exp Neurol. Oct 2. 2012 (Epub ahead of print).
25. Geller E., Yuwiler A., Freeman B.J., Ritvo E. Platelet size, number, and serotonin content in blood of autistic, childhood schizophrenic, and normal children. J. Autism Dev. Disord. 1988, 18:119-126.
26. Gershon M.D. Review article: serotonin receptors and transporters: roles in normal and abnormal gastrointestinal motility. Aliment. Pharmacol. Ther. 2004, 20:3-14.
27. Hanley H.G., Stahl S.M., Freedman D.X. Hyperserotonemia and amine metabolites in autistic and retarded children. Arch. Gen. Psychiatry 1977, 34:521-531.
28. Hoshino Y., Yamamoto T., Kaneko M., Tachibana R., Watanabe M., Ono Y., Kumashiro H. Blood serotonin and free tryptophan concentration in autistic children. Neuropsychobiology 1984, 11:22-27.
29. Hranilovic D., Bujas-Petkovic Z., Vragovic R., Vuk T., Hock K., Jernej B. Hyperserotonemia in adults with autistic disorder. J. Autism Dev. Disord. 2007, 37:1934-1940.
30. 3H-serotonin uptake by platelets in infantile autism and developmental language disorder (including five pairs of twins). J. Autism Dev. Disord. 1986, 16:69-76.
31. Kuperman S., Beeghly J.H., Burns T.L., Tsai L.Y. Serotonin relationships of autistic probands and their first-degree relatives. J. Am. Acad. Child Psychiatry 1985, 24:186-190.
32. Leboyer M., Philippe A., Bouvard M., Guilloud-Bataille M., Bondoux D., Tabuteau F. Whole blood serotonin and plasma beta-endorphin in autistic probands and their first-degree relatives. Biol. Psychiatry 1999, 45:158-163.
33. Lesch K.P., Wolozin B.L., Murphy D.L., Riederer P. Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J. Neurochem. 1993, 60:2319-2322.
34. Leventhal B.L., Cook E.H., Morford M., Ravitz A., Freedman D.X. Relationships of whole blood serotonin and plasma norepinephrine within families. J. Autism Dev. Disord. 1990, 20:499-511.
35. Marazziti D., Muratori F., Cesari A., Masala I., Baroni S., Giannaccini G., Dell'Osso L., Cosenza A., Pfanner P., Cassano G.B. Increased density of the platelet serotonin transporter in autism. Pharmacopsychiatry 2000, 33:165-168.
36. McBride P.A., Anderson G.M., Hertzig M.E., Snow M.E., Thompson S.M., Khait V.D., Shapiro T., Cohen D.J. Effects of diagnosis, race, and puberty on platelet serotonin levels in autism and mental retardation. J. Am. Acad. Child Adolesc. Psychiatry 1998, 37:767-776.
37. Mei H., Cuccaro M.L., Martin E.R. Multifactor dimensionality reduction-phenomics: a novel method to capture genetic heterogeneity with use of phenotypic variables. Am. J. Hum. Genet. 2007, 81:1251-1261.
38. Minderaa R.B., Anderson G.M., Volkmar F.R., Akkerhuis G.W., Cohen D.J. Urinary 5-hydroxyindoleacetic acid and whole blood serotonin and tryptophan in autistic and normal subjects. Biol. Psychiatry 1987, 22:933-940.
39. Minderaa R.B., Anderson G.M., Volkmar F.R., Harcherick D., Akkerhuis G.W., Cohen D.J. Whole blood serotonin and tryptophan in autism: temporal stability and the effects of medication. J. Autism Dev. Disord. 1989, 19:129-136.
40. Mitchell S., Cardy J.O., Zwaigenbaum L. Differentiating autism spectrum disorder from other developmental delays in the first two years of life. Dev. Disabil. Res. Rev. 2011, 17:130-140.
41. Mulder E.J., Anderson G.M., Kema I.P., de Bildt A., van Lang N.D., den Boer J.A., Minderaa R.B. Platelet serotonin levels in pervasive developmental disorders and mental retardation: diagnostic group differences, within-group distribution, and behavioral correlates. J. Am. Acad. Child Adolesc. Psychiatry 2004, 43:491-499.
42. Murphy D.G., Daly E., Schmitz N., Toal F., Murphy K., Curran S., Erlandsson K., Eersels J., Kerwin R., Ell P., Travis M. Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger[U+05F3]s syndrome: an in vivo SPECT study. Am. J. Psychiatry 2006, 163:934-936.
43. Murphy D.L., Lesch K.P. Targeting the murine serotonin transporter: insights into human neurobiology. Nat. Rev. Neurosci. 2008, 9:85-96.
44. Nakamura K., Sekine Y., Ouchi Y., Tsujii M., Yoshikawa E., Futatsubashi M., Tsuchiya K.J., Sugihara G., Iwata Y., Suzuki K., Matsuzaki H., Suda S., Sugiyama T., Takei N., Mori N. Brain serotonin and dopamine transporter bindings in adults with high functioning autism. Arch. Gen. Psychiatry 2010, 67:59-68.
45. Napolioni V., Lombardi F., Sacco R., Curatolo P., Manzi B., Alessandrelli R., Militerni R., Bravaccio C., Lenti C., Saccani M., Schneider C., Melmed R., Pascucci T., Puglisi-Allegra S., Reichelt K.L., Rousseau F., Lewin P., Persico A.M. Family-based association study of ITGB3 in autism spectrum disorder and its endophenotypes. Eur. J. Hum. Genet. 2011, 19:353-359.
46. Perry B.D., Cook E.H., Leventhal B.L., Wainwright M.S., Freedman D.X. Platelet 5-HT2 serotonin receptor binding sites in autistic children and their first-degree relatives. Biol. Psychiatry 1991, 30:121-130.
47. Persico A.M., Pascucci T., Puglisi-Allegra S., Militerni R., Bravaccio C., Schneider C. Serotonin transporter gene promoter variants do not explain the hyperserotoninemia in autistic children. Mol. Psychiatry 2002, 7:795-800.
48. Persico A.M. Developmental roles of the serotonin transporter. Experimental Models in Serotonin Transporter Research 2009, 78-104. Cambridge University Press, UK. A.V. Kalueff (Ed.).
49. Piven J., Tsai G.C., Nehme E., Coyle J.T., Chase G.A., Folstein S.E. Platelet serotonin, a possible marker for familial autism. J. Autism Dev. Disord. 1991, 21:51-59.
50. Prasad H.C., Zhu C.B., McCauley J.L., Samuvel D.J., Ramamoorthy S., Shelton R.C., Hewlett W.A., Sutcliffe J.S., Blakely R.D. Human serotonin transporter variants display altered sensitivity to protein kinase G and p38 mitogen-activated protein kinase. Proc. Natl. Acad. Sci. USA 2005, 102:11545-11550.
51. Ritvo E.R., Yuwiler A., Geller E., Ornitz E.M., Saeger K., Plotkin S. Increased blood serotonin and platelets in early infantile autism. Arch. Gen. Psychiatry 1970, 23:566-572.
52. Ruggeri, B., Sarkans, U., Schumann, G., Persico, A.M., 2013. Biomarkers in Autism Spectrum Disorder: The Old and The New. Psychopharmacology (Berl.), 2013 Oct 6. [Epub ahead of print] PubMed PMID: 24096533.
53. Sacco R., Curatolo P., Manzi B., Militerni R., Bravaccio C., Frolli A., Lenti C., Saccani M., Elia M., Reichelt K.L., Pascucci T., Puglisi-Allegra S., Persico A.M. Principal pathogenetic components and biological endophenotypes in autism spectrum disorders. Autism Res. 2010, 3:237-252.
54. Schain R.J., Freedman D.X. Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J. Pediatr. 1961, 58:315-320.
55. Spivak B., Golubchik P., Mozes T., Vered Y., Nechmad A., Weizman A., Strous R.D. Low platelet-poor plasma levels of serotonin in adult autistic patients. Neuropsychobiology 2004, 50:157-160.
56. State M.W., Levitt P. The conundrums of understanding genetic risks for autism spectrum disorders. Nat. Neurosci. 2011, 14:1499-1506.
57. Stone J.L., Merriman B., Cantor R.M., Yonan A.L., Gilliam T.C., Geschwind D.H., Nelson S.F. Evidence for sex-specific risk alleles in autism spectrum disorder. Am. J. Hum. Genet. 2004, 75:1117-1123.
58. Tordjman S., Anderson G.M., McBride P.A., Hertzig M.E., Snow M.E., Hall L.M., Ferrari P., Cohen D.J. Plasma androgens in autism. J. Autism. Dev. Disord. 1995, 25:295-304.
59. Veenstra-VanderWeele J., Blakely R.D. Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments. Neuropsychopharmacology 2012, 37:196-212.
60. Veenstra-VanderWeele J., Muller C.L., Iwamoto H., Sauer J.E., Owens W.A., Shah C.R., Cohen J., Mannangatti P., Jessen T., Thompson B.J., Ye R., Kerr T.M., Carneiro A.M., Crawley J.N., Sanders-Bush E., McMahon D.G., Ramamoorthy S., Daws L.C., Sutcliffe J.S., Blakely R.D. Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proc. Natl. Acad. Sci. USA 2012, 109:5469-5474.
61. Vered Y., Golubchik P., Mozes T., Strous R., Nechmad A., Mester R., Weizman A., Spivak B. The platelet-poor plasma 5-HT response to carbohydrate rich meal administration in adult autistic patients compared with normal controls. Hum. Psychopharmacol. 2003, 18:395-399.
62. Walker E., Hernandez A.V., Kattan M.W. Meta-analysis: its strengths and limitations. Cleve Clin. J. Med. 2008, 75:431-439.
63. Walsh P., Elsabbagh M., Bolton P., Singh I. In search of biomarkers for autism: scientific, social and ethical challenges. Nat. Rev. Neurosci. 2011, 12:603-612.
64. Wan M.W., Green J., Elsabbagh M., Johnson M., Charman T., Plummer F. Quality of interaction between at-risk infants and caregiver at 12-15 months is associated with 3-year autism outcome. J. Child. Psychol. Psychiatry 2013, 54:763-771.
65. Weiss L.A., Veenstra-Vanderweele J., Newman D.L., Kim S.J., Dytch H., McPeek M.S., Cheng S., Ober C., Cook E.H., Abney M. Genome-wide association study identifies ITGB3 as a QTL for whole blood serotonin. Eur. J. Hum. Genet. 2004, 12:949-954.
66. Weiss L.A., Abney M., Cook E.H., Ober C. Sex-specific genetic architecture of whole blood serotonin levels. Am. J. Hum. Genet. 2005, 76:33-41.
67. Weiss L.A., Kosova G., Delahanty R.J., Jiang L., Cook E.H., Ober C. Variation in ITGB3 is associated with whole-blood serotonin level and autism susceptibility. Eur. J. Hum. Genet. 2006, 14:923-931.
68. Weiss L.A., Ober C., Cook E.H. ITGB3 shows genetic and expression interaction with SLC6A4. Hum. Genet. 2006, 120:93-100.
69. Yuwiler A., Plotkin S., Geller E., Ritvo E.R. A rapid accurate procedure for the determination of serotonin in whole human blood. Biochem. Med. 1970, 3:426-431.
70. Yuwiler A., Ritvo E.R., Bald D., Kipper D., Koper A. Examination of circadian rhythmicity of blood serotonin and platelets in autistic and non-autistic children. J. Autism Child Schizophr. 1971, 1:421-435.
71. Yuwiler A., Shih J.C., Chen C.H., Ritvo E.R., Hanna G., Ellison G.W., King B.H. Hyperserotoninemia and antiserotonin antibodies in autism and other disorders. J. Autism. Dev. Disord. 1992, 22:33-45.
72. Zalsman G., Aslanov-Farbstein D., Rehavi M., Roz N., Vermeiren R., Laor N., Weizman A., Toren P. Platelet vesicular monoamine transporter 2 density in the disruptive behavior disorders. J. Child Adolesc. Psychopharmacol. 2011, 21:341-344.